Evidence map›Paper›PMID 36906279›Full record

ReviewFEMS microbiology reviews2023

Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs.

Masanori Asai, Yanwen Li, Sandra M Newton, Brian D Robertson, Paul R Langford

Open access · hybridFull text readReview
In one paragraph

Review in FEMS microbiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Design, synthesis, and biological evaluation of tyrcinnamine derivatives as bactericides.Journal of enzyme inhibition and medicinal chemistry · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Journal of bacteriology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. BioluminescentFrontiers in cellular and infection microbiology · 2026
    Article
  15. Frontiers in microbiology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Masanori AsaiSection of Paediatric Infectious Disease, Department of Infectious Disease, St Mary's campus, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0001-9931-3549
Yanwen LiSection of Paediatric Infectious Disease, Department of Infectious Disease, St Mary's campus, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0002-4196-1751
Sandra M NewtonSection of Paediatric Infectious Disease, Department of Infectious Disease, St Mary's campus, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0001-6545-9558
Brian D RobertsonCentre for Bacterial Resistance Biology, Department of Infectious Disease, South Kensington campus, Imperial College London, London SW7 2AZ, United Kingdom.ORCID 0000-0001-5785-5307
Paul R LangfordSection of Paediatric Infectious Disease, Department of Infectious Disease, St Mary's campus, Imperial College London, London W2 1PG, United Kingdom.ORCID 0000-0002-6368-4724
St Mary's Hospital · GBImperial College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/S005846/1Medical Research Council MR/P028225/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/R001596/1
6 · The paper itself

Abstract

Galleria mellonella (greater wax moth) larvae are used widely as surrogate infectious disease models, due to ease of use and the presence of an innate immune system functionally similar to that of vertebrates. Here, we review G. mellonella-human intracellular bacteria pathogen infection models from the genera Burkholderia, Coxiella, Francisella, Listeria, and Mycobacterium. For all genera, G. mellonella use has increased understanding of host-bacterial interactive biology, particularly through studies comparing the virulence of closely related species and/or wild-type versus mutant pairs. In many cases, virulence in G. mellonella mirrors that found in mammalian infection models, although it is unclear whether the pathogenic mechanisms are the same. The use of G. mellonella larvae has speeded up in vivo efficacy and toxicity testing of novel antimicrobials to treat infections caused by intracellular bacteria: an area that will expand since the FDA no longer requires animal testing for licensure. Further use of G. mellonella-intracellular bacteria infection models will be driven by advances in G. mellonella genetics, imaging, metabolomics, proteomics, and transcriptomic methodologies, alongside the development and accessibility of reagents to quantify immune markers, all of which will be underpinned by a fully annotated genome.

Indexed as

MothsAnimalsBacteriaDisease Models, AnimalHumansLarvaMammalsVirulenceantimicrobialGalleria mellonellainsectintracellular pathogenmycobacteriavirulence

Identifiers

PMID36906279
PMCPMC10045907
OpenAlexW4323928364

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read66
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.